Sinovac's vaccine is at least 98.9% effective in producing antibodies among young - Printable Version
+- SG Talk (https://sgtalk.net)
+-- Forum: SG Talk (https://sgtalk.net/Forum-SG-Talk)
+--- Forum: Market Talk (https://sgtalk.net/Forum-Market-Talk)
+--- Thread: Sinovac's vaccine is at least 98.9% effective in producing antibodies among young (/Thread-Sinovac-s-vaccine-is-at-least-98-9-effective-in-producing-antibodies-among-young)
+- SG Talk (https://sgtalk.net)
+-- Forum: SG Talk (https://sgtalk.net/Forum-SG-Talk)
+--- Forum: Market Talk (https://sgtalk.net/Forum-Market-Talk)
+--- Thread: Sinovac's vaccine is at least 98.9% effective in producing antibodies among young (/Thread-Sinovac-s-vaccine-is-at-least-98-9-effective-in-producing-antibodies-among-young)
Sinovac's vaccine is at least 98.9% effective in producing antibodies among young - theold - 20-07-2021
China's Sinovac COVID-19 vaccine has been approved for emergency use among population aged between 3 and 17 years old, after phase-II clinic trial data suggests it is at least 98.9 percent effective in producing antibodies, a higher efficacy than in population over 18 years old.
The experiment included 180 volunteers within the age group. Three months after vaccination, the production of antibodies among population aged 3 to 17 years old was 98.9 to 100 percent depending on the dosage of the inoculation, the company announced on Monday.
https://www.globaltimes.cn/page/202107/1229068.shtml